# Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients

> **NCT00384410** · PHASE2 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 16 (—)

## Conditions studied

- Pain
- Insomnia

## Interventions

- **DRUG:** Nabilone

## Key facts

- **NCT ID:** NCT00384410
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 16 (—)
- **Last updated:** 2006-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384410, "Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00384410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*